MMTC planning to export engineering goods, pharma products

As part of its business diversification strategy, MMTC Ltd., the state-owned trading entity, aims to commence exports of engineering goods and pharmaceutical products from Q1 of next fiscal.
The company is looking at transactions in new commodities and go beyond its forte in trade of bullion and major bulk minerals like iron ore and chromite.
“We have already empanelled suppliers for engineering goods exports. They are expected to take off from Q1 of next fiscal. Engineering goods will be primarily exported to African markets. We have also identified some Asian markets like Sri Lanka and Bangladesh,” said a senior MMTC executive.
MMTC is awaiting award of drug license to start exports of pharmaceutical products. Amongst the new pro-ducts identified for trade, minor minerals are targeted for exports alone and will be canalised through MMTC. The other identified commodities are meant for two-way trade. The company has initiated action on exports of minor mine-rals like feldspar and bentonite.
Historically known for its strengths in trade of bulk minerals like iron ore and chrome ore, MMTC is witnessing a downtrend in exports of these minerals in value and volume terms. In FY18, low grade chrome ore and chrome concentrates exports plunged 58% as a steep export tax of 30% weighed on exports. Total volumes exported in last fiscal were only 95,000-tonnes, down from 225,000-tonnes shipped in FY17.
MMTC is one of the premier bullion traders in the country with the precious metals division contributing significantly to its turnover.
The company has delineated a roadmap to double its top-line in the next five years. The surge in turnover is expected to be fuelled by MMTC’s diversification into new business areas.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
Recommend Reading
-
Uzbekistan Bets $17 Billion on Chemical Industry Upgrade
-
ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk
-
US MDI Supply Squeeze Triggers Price Hikes
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
This week, PVC market continues to decline in China
-
This Week's Aniline Market Remains Firm (10.20-10.24)
-
June 8th: Shandong Asphalt Supply Declines, Market Continues to Rise
-
China's urea market shows a strong upward trend (10.20-10.24)
-
Supply Pressure Doubles, Hydrogen Peroxide Prices Continue to Fall in China